31 – 40 of 173
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
CYP2D6 genotype predicts tamoxifen discontinuation and drug response : a secondary analysis of the KARISMA trial
(
- Contribution to journal › Article
-
Mark
Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: a prospective nested case-control study
(
- Contribution to journal › Article
-
Mark
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
(
- Contribution to journal › Article
-
Mark
Adipocytes Under Obese-Like Conditions Change Cell Cycle Distribution and Phosphorylation Profiles of Breast Cancer Cells : The Adipokine Receptor CAP1 Matters
(
- Contribution to journal › Article
-
Mark
Low-Dose Tamoxifen for Mammographic Density Reduction : A Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Local biomarkers involved in the interplay between obesity and breast cancer
(
- Contribution to journal › Scientific review
-
Mark
Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer : A prospective cohort study
(
- Contribution to journal › Article
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients
(
- Contribution to journal › Article